Armodafinil

Eugeroic

Wakefulness and alertness

Reading this compound Reference only

Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.

Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.

Mechanism & Use

Compound type: Small molecule
Primary mechanism: Dopamine transporter inhibition/wakefulness pathways
Primary market use: Narcolepsy/shift work

Pharmacology

Molecular weight (Da): 273.4
Oral bioavailability: ~80%+
Half-life: ~15 h
Route tags: Route-dependent / verify
Evidence level: Approved
Clinical status: Approved
Value-for-money score: 8 / 10

Reported protocol signal

No popular protocol verified yet; keep as reference compound until protocol signal is added.

For orientation only. See disclaimer — always consult a licensed clinician before use.

Notes

Classic transient eugeroic

Sources

https://www.fda.gov/drugs